Physician profile
Robert C Williams
NPI 1740692839
$8,047.75
in general payments reported to CMS, 2019-2025
13 companies · $582 in 2025
The $582 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,298 · 2020: $1,724 · 2021: $1,351 · 2022: $2,649 · 2023: $265 · 2024: $179 · 2025: $582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $692 · Travel and Lodging: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $691.78 |
| Travel and Lodging | $334.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medwest Associates | $3,751.68 | 2021-2023 | |
| Encore Medical, LP | $1,770.29 | 2019-2020 | |
| Medical Device Business Services, INC. | $947.61 | 2019 | |
| Stryker Corporation | $698.14 | 2019-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform, Tornier Perform Reversed Glenoid |
| Smith+Nephew, INC. | $343.87 | 2019-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Depuy Synthes Sales INC. | $150.54 | 2021-2023 | Na |
| Medacta USA, INC. | $98.35 | 2021 | |
| Lima USA, INC. | $95.12 | 2020 | |
| Oak Med, INC. | $57.07 | 2024 | |
| Catalyst Orthoscience | $54.85 | 2022 | |
| Djo, LLC | $35.72 | 2023-2025 | Cmf |
| Heron Therapeutics, INC. | $25.67 | 2023 | Zynrelef |
| Orthopediatrics Corp. | $18.84 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.